目前沒有任何討論
UTHR 聯合治療
464.93
7.06
(-1.5%)
聯合治療 UTHR 生物技術:藥物製劑
464.93
7.06
(-1.5%)
單位:美金千元
| 科目 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | 2022/Q3 | 2022/Q2 | 2022/Q1 | 2021/Q4 | 2021/Q3 | 2021/Q2 | 2021/Q1 | 2020/Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
營業現金流
| 562,100 | 191,700 | 461,200 | 341,200 | 377,200 | 232,200 | 376,500 | 150,700 | 346,200 | 106,300 | 374,800 | 128,200 | 258,600 | 127,000 | 288,700 | 174,600 | 185,600 | 148,200 | 89,800 | 126,200 |
稅後淨利
| 338,700 | 309,500 | 322,200 | 301,300 | 309,100 | 278,100 | 306,600 | 217,100 | 267,600 | 259,200 | 240,900 | 132,100 | 239,300 | 116,000 | 239,900 | 112,200 | 162,700 | 172,600 | 28,300 | 98,800 |
折舊費用
| 21,900 | 21,100 | 19,800 | 19,700 | 19,100 | 18,700 | 15,000 | 13,700 | 13,300 | 12,900 | 13,300 | 13,200 | 12,900 | 12,700 | 12,500 | 12,600 | 12,400 | 12,400 | 12,500 | 13,100 |
調整項目
| - | - | 41,200 | 24,400 | 36,000 | 44,200 | 15,100 | 11,600 | 19,300 | 13,500 | -6,600 | 70,700 | 13,700 | 112,300 | -31,600 | 82,900 | 56,800 | 36,900 | 70,100 | 57,000 |
應收帳款增減
| - | - | -42,700 | 62,500 | -51,100 | 16,500 | -28,300 | -20,300 | 14,000 | -138,100 | 85,900 | 11,300 | -58,300 | -2,800 | 28,100 | 14,100 | -39,300 | -32,400 | 16,300 | -5,100 |
存貨增減
| - | - | -11,200 | -11,600 | -11,300 | -14,700 | -9,300 | -7,000 | -3,100 | -1,000 | -2,500 | -13,900 | -600 | -4,600 | 5,700 | -100 | -8,200 | 3,000 | -2,200 | -800 |
其他營業活動資產增減
| - | - | 134,500 | -37,100 | 42,400 | -136,400 | 75,500 | -41,300 | -4,300 | -78,200 | 41,000 | -94,300 | 29,300 | -130,500 | 44,900 | -12,600 | -18,600 | -71,500 | -10,200 | -47,500 |
負債增減
| - | - | -2,600 | -18,000 | 33,000 | 25,800 | 1,900 | -23,100 | 39,400 | 38,000 | 2,800 | 9,100 | 22,300 | 23,900 | -10,800 | -34,500 | 19,800 | 27,200 | -25,000 | 10,700 |
投資現金流
| 140,900 | -299,900 | -164,700 | -123,200 | -114,900 | -80,000 | 735,300 | 42,100 | -313,400 | -227,200 | -221,100 | -189,300 | -94,000 | -169,000 | -359,200 | -195,800 | -235,900 | -48,900 | -6,300 | -63,800 |
資本支出增減
| -216,000 | -62,200 | -74,900 | -86,700 | -76,500 | -45,100 | -38,200 | -78,700 | -65,700 | -44,700 | -41,300 | -39,500 | -68,800 | -17,000 | -13,500 | -70,600 | -23,300 | -16,300 | -10,600 | -12,300 |
投資增減
| 392,600 | -237,100 | -80,600 | -30,500 | -20,600 | -34,500 | 777,800 | 218,700 | -237,100 | -178,800 | -179,800 | -149,800 | -25,200 | -152,000 | -345,700 | -125,200 | -220,400 | -24,800 | 4,300 | -51,500 |
其他投資活動現金流量
| - | - | -9,200 | -6,000 | -17,800 | -400 | -4,300 | -97,900 | -10,600 | -3,700 | - | - | - | - | - | - | 7,800 | -7,800 | - | - |
融資現金流
| -956,000 | -198,600 | -93,800 | -74,700 | -64,100 | -48,000 | -1,068,000 | -92,800 | 7,600 | 24,700 | 48,600 | 55,500 | 7,000 | 23,900 | -11,000 | 7,500 | 16,600 | 10,600 | 10,100 | 6,100 |
賣出及買回股票增減
| -1,000,500 | -20,500 | 21,500 | 25,600 | 36,300 | 52,100 | -953,900 | 7,300 | 7,800 | 24,700 | 64,800 | 55,500 | 7,300 | 23,900 | 7,600 | 7,700 | 16,800 | 10,800 | 20,300 | 7,900 |
借款增減
| 0 | -200,000 | -100,000 | -100,000 | -100,000 | -100,000 | -100,000 | -100,000 | - | - | - | - | - | - | - | - | - | - | - | - |
其他籌資活動現金流量
| 0 | 3,800 | -15,300 | -300 | -400 | -100 | -11,400 | -100 | -200 | - | -13,500 | - | -300 | - | -11,100 | -200 | -200 | -200 | -10,200 | -100 |
自由現金流
| 346,100 | 129,500 | 386,300 | 254,500 | 300,700 | 187,100 | 338,300 | 72,000 | 280,500 | 61,600 | 333,500 | 88,700 | 189,800 | 110,000 | 275,200 | 104,000 | 162,300 | 131,900 | 79,200 | 113,900 |
淨現金流
| -253,000 | -306,800 | 202,700 | 143,300 | 198,200 | 104,200 | 43,800 | 100,000 | 40,400 | -96,200 | 202,300 | -5,600 | 171,600 | -18,100 | -81,500 | -13,700 | -33,700 | 109,900 | 93,600 | 68,500 |